
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing

Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
Ventripoint, NVHA to develop model for AI heart care
NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways
Mindbio closes $1.1-million private placement
Healthcare AI Exits Pilot Phase, Enters Production Deployment
Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate Update
Ventripoint Unveils a Global Model for A.I.-Enhanced Heart Care through Partnership with the Nisga'a Valley Health Authority
MindBio Raises $1.1 Million in Private Placement
Pharmacorp Rx enters deal to acquire pharmacy files
LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
Netramark Holdings expands into phase three programs
Microbix Schedules Release of Results for Q4 Fiscal 2025
Betterlife hires YAFO as adviser in Greater China
Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting